PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+4.97%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$312M
AUM Growth
+$312M
(+2.8%)
Cap. Flow
+$21.2M
Cap. Flow
% of AUM
6.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
4
Closed
1
Top Buys
| 1 |
Bolt Biotherapeutics
BOLT
|
$62.2M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$21M |
| 2 |
Vaxcyte
PCVX
|
$16.1M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$2.97M |
| 4 |
Iterum Therapeutics
ITRM
|
$935K |
| 5 |
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
|
$8.13K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $109M | 35.05% | 908,708 -174,636 | -16% | -$21M |
|
|
2
Bolt Biotherapeutics
BOLT
$9.85M
| $62.2M | 19.97% | +1,891,467 | New | +$62.2M |
|
|
INZY
3
DELISTED
Inozyme Pharma
INZY
| $31.5M | 10.11% | 1,591,154 | – | – |
|
|
4
Vaxcyte
PCVX
$4B
| $27.8M | 8.91% | 1,405,421 -817,549 | -37% | -$16.1M |
|
|
AKUS
5
DELISTED
Akouos, Inc. Common Stock
AKUS
| $24.9M | 7.98% | 1,794,088 | – | – |
|
6
Aligos Therapeutics
ALGS
$73.3M
| $19.9M | 6.4% | 876,548 | – | – |
|
|
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $17.1M | 5.5% | 1,598,379 | – | – |
|
|
8
Arcutis Biotherapeutics
ARQT
$1.86B
| $16.5M | 5.28% | 569,041 -102,675 | -15% | -$2.97M |
|
|
ETTX
9
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $2.52M | 0.81% | 1,176,378 -3,800 | -0.3% | -$8.13K |
|
|
10
Iterum Therapeutics
ITRM
$30.2M
| – | – | -945,085 | Closed | -$935K |
|